Review: taking Warfarin sodium and Salmon oil together


Summary

Drug interactions are reported among people who take Warfarin sodium and Salmon oil together. This review analyzes the effectiveness and drug interactions between Warfarin sodium and Salmon oil. It is created by eHealthMe based on reports of 2,900 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Warfarin Sodium

Warfarin sodium has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. (latest outcomes from Warfarin sodium 53,624 users)

Salmon Oil

Salmon oil has active ingredients of fish oil. It is often used in supplementation therapy. (latest outcomes from Salmon oil 178 users)

On Sep, 16, 2016

2,900 people who take Warfarin Sodium, Salmon Oil are studied.


Number of reports submitted per year:

Warfarin sodium and Salmon oil drug interactions.

Drug effectiveness over time:

Warfarin Sodium:
  • < 1 month: 33.0% - (1 of 3 people)
  • 1 - 6 months: 33.0% - (2 of 6 people)
  • 6 - 12 months: 66.0% - (2 of 3 people)
  • 1 - 2 years: 75.0% - (3 of 4 people)
  • 2 - 5 years: 60.0% - (3 of 5 people)
  • 5 - 10 years: 100.0% - (10 of 10 people)
  • 10+ years: 100.0% - (6 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Salmon Oil:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 5 people)
  • 6 - 12 months: 50.0% - (1 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 4 people)
  • 2 - 5 years: 71.0% - (5 of 7 people)
  • 5 - 10 years: 0.0% - (0 of 7 people)
  • 10+ years: 50.0% - (2 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Warfarin Sodium:
  • female: 80.0% - (12 of 15 people)
  • male: 68.0% - (15 of 22 people)
Salmon Oil:
  • female: 30.0% - (3 of 10 people)
  • male: 25.0% - (5 of 20 people)

Drug effectiveness by age:

Warfarin Sodium:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 76.0% - (10 of 13 people)
  • 60+: 68.0% - (15 of 22 people)
Salmon Oil:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 2 people)
  • 50-59: 22.0% - (2 of 9 people)
  • 60+: 33.0% - (6 of 18 people)

Most common drug interactions over time *:

< 1 month:
  • international normalised ratio increased
  • gastrointestinal haemorrhage
  • anaemia
  • haematuria
  • atrial fibrillation
  • hypotension
  • diarrhoea
  • blood glucose increased
  • cardiac arrest
  • depression
1 - 6 months:
  • anaemia
  • gastrointestinal haemorrhage
  • atrial fibrillation
  • hypotension
  • chest discomfort
  • chest pain
  • chronic gastrointestinal bleeding
  • dyspnoea
  • haematuria
  • insomnia
6 - 12 months:
  • epistaxis
  • haematuria
  • stroke
  • atrial fibrillation
  • dyspepsia
  • fatigue
  • loss of hair
  • malaise
  • myocardial infarction
  • vomiting
1 - 2 years:
  • cerebral thrombosis
  • eye disorder
  • headache
  • superior sagittal sinus thrombosis
  • abdominal pain
  • anaemia
  • chest pain
  • cough aggravated
  • dyspnoea
  • exhaustion, fatigue, lethargy, tiredness, weariness
2 - 5 years:
  • lightheadedness
  • muscle twitching
  • muscle weakness
  • shaking palsy
  • vertigo positional
  • myelodysplastic syndrome
  • tinnitus aggravated
  • anaemia
  • epistaxis
  • gynaecomastia
5 - 10 years:
  • insomnia
  • liver function tests nos abnormal
  • ulcer
  • anaemia
  • bleeding time prolonged
  • cerebrovascular accident
  • chest pain
  • fall
  • gynaecomastia
  • hair loss
10+ years:
  • chronic obstructive pulmonary disease
  • death
  • pain exacerbated
  • constipation
  • dizziness
  • pneumonia
  • skin redness or inflammation
  • acute respiratory failure
  • adrenal disorder
  • anaemia
not specified:
  • dyspnoea
  • pain
  • fatigue
  • atrial fibrillation
  • nausea
  • oedema peripheral
  • diarrhoea
  • dizziness
  • pneumonia
  • asthenia

Most common drug interactions by gender *:

female:
  • dyspnoea
  • pain
  • diarrhoea
  • oedema peripheral
  • nausea
  • fatigue
  • pain in extremity
  • back pain
  • chest pain
  • arthralgia
male:
  • fatigue
  • dyspnoea
  • atrial fibrillation
  • pain
  • pneumonia
  • dizziness
  • asthenia
  • oedema peripheral
  • nausea
  • anaemia

Most common drug interactions by age *:

10-19:
  • arthritis
  • colitis ulcerative
  • colonic polyp
  • inflammatory bowel disease
  • intestinal haemorrhage
  • abdominal pain
  • activities of daily living impaired
  • anxiety
  • atelectasis
  • atrial fibrillation
20-29:
  • drug ineffective
  • liver injury
  • gait disturbance
  • arthralgia
  • cerebrovascular accident
  • gastrointestinal disorder
  • pulmonary embolism
  • abdominal pain upper
  • abscess
  • alcoholic liver disease
30-39:
  • headache
  • pain in extremity
  • nausea
  • catheter site inflammation
  • catheter site rash
  • catheter site swelling
  • device related infection
  • infusion site pain
  • purulent discharge
  • cerebral thrombosis
40-49:
  • pain
  • arthralgia
  • oedema peripheral
  • pain in extremity
  • abdominal pain
  • back pain
  • depression
  • abdominal pain upper
  • mitral valve incompetence
  • arthritis
50-59:
  • dyspnoea
  • diarrhoea
  • nausea
  • vomiting
  • pain
  • chest pain
  • fatigue
  • anaemia
  • pain in extremity
  • atrial fibrillation
60+:
  • fatigue
  • dyspnoea
  • atrial fibrillation
  • diarrhoea
  • asthenia
  • nausea
  • pain
  • oedema peripheral
  • international normalised ratio increased
  • fall

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Warfarin sodium and Salmon oil?

Can you answer these questions?

More questions for: Warfarin sodium, Salmon oil

You may be interested in these reviews

More reviews for: Warfarin sodium, Salmon oil

On eHealthMe, Warfarin sodium (warfarin sodium) is often used to treat atrial fibrillation/flutter. Salmon oil (fish oil) is often used to treat supplementation therapy. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.